Clinical analysis of human umbilical cord mesenchymal stem cell allotransplantation in patients with premature ovarian insufficiency
Cell Proliferation2020Vol. 53(12), pp. e12938–e12938
Citations Over TimeTop 10% of 2020 papers
Yan Long, Yixuan Wu, Li Li, Jun Wu, Feiyan Zhao, Zheng Gao, Wenjing Liu, Tianda Li, Yong Fan, Jie Hao, Jianqiao Liu, Hongmei Wang
Abstract
The clinical trial result sugggests a possible therapy for POI by UCMSC transplantation.
Related Papers
- → Expanding our knowledge of premature ovarian insufficiency(2020)13 cited
- → Clinical and Genetic Investigation of Premature Ovarian Insufficiency Cases from Turkey(2019)14 cited
- → The need to identify novel biomarkers for prediction of premature ovarian insufficiency (POI)(2022)3 cited
- → What is the most effective hormone treatment for women with premature ovarian insufficiency (POI), in both the short and long-term?(2021)1 cited
- → Premature Ovarian Failure: Fertility Challenge(2014)